Mentice AB (publ) (STO:MNTC)

Market Cap	431.73M -17.2%
Revenue (ttm)	286.97M -4.1%
Net Income	-21.30M
EPS	-0.74
Shares Out	28.13M
PE Ratio	n/a
Forward PE	537.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,273
Average Volume	32,127
Open	15.60
Previous Close	15.60
Day's Range	15.35 - 15.85
52-Week Range	8.50 - 21.30
Beta	0.46
RSI	75.80
Earnings Date	Jul 23, 2026

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as t...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 129
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2025, Mentice AB's revenue was 279.09 million, a decrease of -3.87% compared to the previous year's 290.33 million. Losses were -32.33 million, 75.5% more than in 2024.